SCHEMBL8079040

SCHEMBL8079040

COc1ccc(CCCCOc2ccc(CSc3cccc(Cl)c3)nc2C=CC(=O)O)cc1

nearest known ligand 0.85

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8079037 1.00 LTB4R (0.85) LTB4R
SCHEMBL8862133 0.92 LTB4R (1.00) LTB4R
SCHEMBL8075117 0.92 LTB4R (1.00) LTB4R
SCHEMBL8862050 0.92 LTB4R (1.00) LTB4R
SCHEMBL8073842 0.91 LTB4R (0.85) LTB4R
SCHEMBL8073840 0.91 LTB4R (0.85) LTB4R
SCHEMBL8862135 0.91 LTB4R (1.00) LTB4R
SCHEMBL8078852 0.90 LTB4R (0.98) LTB4R
SCHEMBL8075116 0.90 LTB4R (1.00) LTB4R
SCHEMBL8080163 0.89 LTB4R (1.00) LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812194-B1 Use of substituted pyridine compounds for treating atopic dermatitis and contact dermatitis SMITHKLINE BEECHAM CORP (US) 2000-08-16 EP disclosed
US-5656636-A TREATING PSORIASIS SMITHKLINE BEECHAM CORPORATION (US) 1997-08-12 US disclosed
US-5633258-A Pyridine compounds for treating leukotriene-related diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-05-27 US disclosed
US-5631262-A Pyridine compounds for treating leukotriene-related diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-05-20 US disclosed
EP-0604529-A1 PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1994-07-06 EP disclosed
WO-1993006085-A1 PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-01 WO disclosed